Alzheimers Dement

1. DEMARCO ML, Algeciras-Schimnich A, Budelier MM
   Blood tests for Alzheimer's disease: The impact of disease prevalence on test performance.
   Alzheimers Dement. 2024 Mar 6. doi: 10.1002/alz.13762.
   

   >> Share

   
   
2. SEPULVEDA-FALLA D, Velez JI, Acosta-Baena N, Baena A, et al
   Genetic modifiers of cognitive decline in PSEN1 E280A Alzheimer's disease.
   Alzheimers Dement. 2024 Mar 7. doi: 10.1002/alz.13754.
   

   >> Share

   
   

   
   Am J Epidemiol

3. HAYES-LARSON E, Ackley SF, Turney IC, La Joie R, et al
   Considerations for Use of Blood-Based Biomarkers in Epidemiologic Dementia Research.
   Am J Epidemiol. 2024;193:527-535.
   

   >> Share

   
   

   
   BMC Geriatr

4. LYU WJ, Chiu PY, Liu CH, Liao YC, et al
   Determining optimal cutoff scores of Cognitive Abilities Screening Instrument to identify dementia and mild cognitive impairment in Taiwan.
   BMC Geriatr. 2024;24:216.
   

   >> Share

   
   

   
   BMC Neurol

5. KWAK S, Kim H, Kim KY, Oh DY, et al
   Neuroanatomical and neurocognitive correlates of delusion in Alzheimer's disease and mild cognitive impairment.
   BMC Neurol. 2024;24:89.
   

   >> Share

   
   

   
   Brain

6. COOMANS EM, van Westen D, Pichet Binette A, Strandberg O, et al
   Interactions between vascular burden and amyloid-beta pathology on trajectories of tau accumulation.
   Brain. 2023 Sep 18:awad317. doi: 10.1093.
   

   >> Share

   
   
7. DE MEYER S, Blujdea ER, Schaeverbeke J, Reinartz M, et al
   Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes.
   Brain. 2024;147:936-948.
   

   >> Share

   
   
8. RODRIGUEZ-VIEITEZ E, Vannini P, Montal V, Graff C, et al
   Cortical microstructural imaging from diffusion MRI: towards sensitive biomarkers for clinical trials.
   Brain. 2024;147:746-748.
   

   >> Share

   
   

   
   Brain Res

9. LIU R, Guo L, Zhao Y, Wu D, et al
   Study on multi-target effects of the novel HDAC6 inhibitor W5 on Abeta/Cu(2+)-induced Alzheimer's disease model of rats.
   Brain Res. 2024;1832:148847.
   

   >> Share

   
   
10. MERCERON-MARTINEZ D, Alacan Ricardo L, Bejerano Pina A, Orama Rojo N, et al
    Amylovis-201 enhances physiological memory formation and rescues memory and hippocampal cell loss in a streptozotocin-induced Alzheimer's disease animal model.
    Brain Res. 2024 Mar 1:148848. doi: 10.1016/j.brainres.2024.148848.
    

    >> Share

    
    
11. WANG W, Zheng WQ, Du X, Chen SC, et al
    Chronic pain exacerbates memory impairment and pathology of Abeta and tau by upregulating IL-1beta and p-65 signaling in a mouse model of Alzheimer's disease.
    Brain Res. 2024 Feb 29:148843. doi: 10.1016/j.brainres.2024.148843.
    

    >> Share

    
    
12. WANG Y, Song C, Yin G, Meng Y, et al
    Alleviation of behavioral deficits, amyloid-beta deposition, and mitochondrial structure damage associated with mitophagy upregulation in AD animal models via AAV9-IGF-1 treatment.
    Brain Res. 2024;1827:148743.
    

    >> Share

    
    

    
    Curr Alzheimer Res

13. TEKADE A, Susar R, Kulkarni G, Surwade S, et al
    Nanostructured Lipid Carriers of Donepezil Hydrochloride for the Treatment of Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Mar 5. doi: 10.2174/0115672050288659240229080535.
    

    >> Share

    
    

    
    Curr Opin Neurol

14. BESCHORNER N, Nedergaard M
    Glymphatic system dysfunction in neurodegenerative diseases.
    Curr Opin Neurol. 2024;37:182-188.
    

    >> Share

    
    

    
    Dement Geriatr Cogn Disord

15. FRESNAIS D, Ihle-Hansen H, Lundstrom E, Andersson AG, et al
    Cerebrovascular Hemodynamics in Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Transcranial Doppler Studies.
    Dement Geriatr Cogn Disord. 2023;52.
    

    >> Share

    
    

    
    Int J Neurosci

16. NOURAEINEJAD A
    The bidirectional links between coronavirus disease 2019 and Alzheimer's disease.
    Int J Neurosci. 2024 Mar 7:1-15. doi: 10.1080/00207454.2024.2327403.
    

    >> Share

    
    

    
    J Am Geriatr Soc

17. SONNEGA A, Mather M, Scommegna P
    The National Institute on Aging Centers on the demography and economics of aging and Alzheimer's disease and Alzheimer's related dementias: History, impact, and future challenges.
    J Am Geriatr Soc. 2024 Mar 6. doi: 10.1111/jgs.18851.
    

    >> Share

    
    

    
    J Biol Chem

18. FEOLE M, Pozo Devoto VM, Dragisic N, Arnaiz C, et al
    Swedish Alzheimer's disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways.
    J Biol Chem. 2024 Mar 4:107137. doi: 10.1016/j.jbc.2024.107137.
    

    >> Share

    
    

    
    JAMA

19. HARRIS E
    Biomarker Changes Can Begin 18 Years Before Alzheimer Disease Diagnosis.
    JAMA. 2024 Mar 6. doi: 10.1001/jama.2024.1568.
    

    >> Share

    
    

    
    N Engl J Med

20. CHIN NA, Dinsmore D, Gonzales T, Groves B, et al
    Alzheimer's Disease - Anti-Amyloid Medications, Early Detection, and Screening.
    N Engl J Med. 2024;390:e22.
    

    >> Share

    
    

    
    Nat Rev Neurol

21. KIANI L
    Regional vulnerability to Abeta and tau pathology.
    Nat Rev Neurol. 2024;20:133.
    

    >> Share

    
    
22. THERRIAULT J, Schindler SE, Salvado G, Pascoal TA, et al
    Biomarker-based staging of Alzheimer disease: rationale and clinical applications.
    Nat Rev Neurol. 2024 Mar 1. doi: 10.1038/s41582-024-00942.
    

    >> Share

    
    

    
    Nature

23. MURDOCK MH, Yang CY, Sun N, Pao PC, et al
    Multisensory gamma stimulation promotes glymphatic clearance of amyloid.
    Nature. 2024;627:149-156.
    

    >> Share

    
    

    
    Neurobiol Aging

24. YILDIRIM E, Akturk T, Hanoglu L, Yener G, et al
    Lower oddball event-related EEG delta and theta responses in patients with dementia due to Parkinson's and Lewy body than Alzheimer's disease.
    Neurobiol Aging. 2024;137:78-93.
    

    >> Share

    
    

    
    Neurobiol Dis

25. ZENG J, Liao Z, Yang H, Wang Q, et al
    T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease.
    Neurobiol Dis. 2024;193:106461.
    

    >> Share

    
    
26. YAMASHIRO K, Takabayashi K, Kamagata K, Nishimoto Y, et al
    Free water in gray matter linked to gut microbiota changes with decreased butyrate producers in Alzheimer's disease and mild cognitive impairment.
    Neurobiol Dis. 2024 Mar 5:106464. doi: 10.1016/j.nbd.2024.106464.
    

    >> Share

    
    

    
    Neurology

27. RAJAN KB, Mcaninch EA, Wilson RS, Dhana A, et al
    Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults.
    Neurology. 2024;102:e209168.
    

    >> Share

    
    

    
    Neurosci Lett

28. SHIGEMATSU K, Komori N, Ideno M, Yamagishi H, et al
    "Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients".
    Neurosci Lett. 2024;825:137705.
    

    >> Share

    
    

    
    PLoS One

29. LI YS, Xia YG, Liu YL, Jiang WR, et al
    Metabolic-dysfunction associated steatotic liver disease-related diseases, cognition and dementia: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0297883.
    

    >> Share

    
    

    
    Rev Neurol (Paris)

30. NICOLAS G
    Lessons from genetic studies in Alzheimer disease.
    Rev Neurol (Paris). 2024 Feb 29:S0035-3787(24)00290.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share